Americans Demand 340B Transparency

A new op-ed for US Today reflects American attitudes surrounding a corrupt drug pricing program. Stephanie Maahs, a healthcare professional from Delaware wrote to USA Today explaining her disappointment with the 340B program. 340B is supposed to help Americans afford drugs by providing discounts to hospitals, but many hospitals are failing to pass those discounts onto their patients. But there are solutions to this growing problem. Maahs sites the 340B ACCESS Act, which was introduced earlier this year, as a solution to return 340B profits to patients. The act increases oversights and strengthens reporting requirements. Our Health Equity advocates for large scale reforms to the 340B program, like the 340B ACCESS Act, that ensure patients have access to the medicine they need at a reasonable price. Read more here.